Nobuyuki Hirohashi

1.1k total citations
38 papers, 687 citations indexed

About

Nobuyuki Hirohashi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Nobuyuki Hirohashi has authored 38 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Nobuyuki Hirohashi's work include Tracheal and airway disorders (5 papers), Airway Management and Intubation Techniques (5 papers) and Immune Response and Inflammation (5 papers). Nobuyuki Hirohashi is often cited by papers focused on Tracheal and airway disorders (5 papers), Airway Management and Intubation Techniques (5 papers) and Immune Response and Inflammation (5 papers). Nobuyuki Hirohashi collaborates with scholars based in Japan, Germany and United States. Nobuyuki Hirohashi's co-authors include David C. Morrison, Koichi Tanigawa, Nobuoki Kohno, Noboru Hattori, Nobuhisa Ishikawa, Shinichiro Ohshimo, Ulrich Costabel, Josune Guzman, Francesco Bonella and Yasushi Horimasu and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Nobuyuki Hirohashi

34 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuyuki Hirohashi Japan 11 256 110 105 103 83 38 687
Lawrence C. Mohr United States 15 233 0.9× 66 0.6× 22 0.2× 77 0.7× 18 0.2× 27 534
H-Erich Wichmann Germany 4 108 0.4× 151 1.4× 20 0.2× 87 0.8× 18 0.2× 6 610
Catherine Mitchell United Kingdom 15 139 0.5× 323 2.9× 32 0.3× 113 1.1× 13 0.2× 33 796
Dillwyn Williams United Kingdom 16 65 0.3× 158 1.4× 22 0.2× 116 1.1× 61 0.7× 27 1.1k
Uwe Kaletsch Germany 17 112 0.4× 116 1.1× 49 0.5× 45 0.4× 22 0.3× 21 1.2k
Zhiguang Zhao China 15 62 0.2× 190 1.7× 76 0.7× 121 1.2× 22 0.3× 52 690
Wann‐Cherng Perng Taiwan 16 325 1.3× 66 0.6× 58 0.6× 93 0.9× 4 0.0× 57 755
Yoonki Hong South Korea 21 527 2.1× 264 2.4× 39 0.4× 150 1.5× 3 0.0× 74 1.1k
Xiaosong Ben China 12 119 0.5× 59 0.5× 15 0.1× 29 0.3× 18 0.2× 45 478

Countries citing papers authored by Nobuyuki Hirohashi

Since Specialization
Citations

This map shows the geographic impact of Nobuyuki Hirohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Hirohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Hirohashi more than expected).

Fields of papers citing papers by Nobuyuki Hirohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyuki Hirohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Hirohashi. The network helps show where Nobuyuki Hirohashi may publish in the future.

Co-authorship network of co-authors of Nobuyuki Hirohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyuki Hirohashi. A scholar is included among the top collaborators of Nobuyuki Hirohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyuki Hirohashi. Nobuyuki Hirohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tanimoto, Keiji, Masami Kanawa, Sho Kurihara, et al.. (2024). Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression. Cancer Science. 115(3). 847–858. 1 indexed citations
3.
Tanimoto, Keiji, et al.. (2022). Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers. 14(19). 4732–4732. 2 indexed citations
4.
5.
Abe, Masanori, Hidetoshi Shiga, Hiroomi Tatsumi, et al.. (2022). Results of the 2018 Japan Society for Blood Purification in Critical Care survey: current status and outcomes. Renal Replacement Therapy. 8(1). 58–58. 7 indexed citations
6.
Tanimoto, Keiji, Kiichi Hirota, Yoshiyuki Matsuo, et al.. (2021). Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. Scientific Reports. 11(1). 16629–16629. 25 indexed citations
7.
Tanimoto, Keiji, Hideaki Nakamura, Akinori Kanai, et al.. (2020). GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A. Carcinogenesis. 41(9). 1184–1194. 16 indexed citations
8.
Tanimoto, Keiji, Takeshi Imura, Shinya Takahashi, et al.. (2019). Simulated microgravity enhances CDDP-induced apoptosis signal via p53-independent mechanisms in cancer cells. PLoS ONE. 14(7). e0219363–e0219363. 22 indexed citations
9.
Nakamura, Hideaki, Hidemasa Bono, Keiko Hiyama, et al.. (2018). Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions. PLoS ONE. 13(2). e0192136–e0192136. 9 indexed citations
10.
Kyo, Michihito, et al.. (2016). Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation: a case report. BMC Pulmonary Medicine. 16(1). 119–119. 3 indexed citations
11.
Hasegawa, Arifumi, Koichi Tanigawa, Akira Ohtsuru, et al.. (2015). Health effects of radiation and other health problems in the aftermath of nuclear accidents, with an emphasis on Fukushima. The Lancet. 386(9992). 479–488. 170 indexed citations
12.
Ohshimo, Shinichiro, Nobuhisa Ishikawa, Yasushi Horimasu, et al.. (2014). Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Medicine. 108(7). 1031–1039. 150 indexed citations
13.
Ohshimo, Shinichiro, Nobuhisa Ishikawa, Yasushi Horimasu, et al.. (2013). MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis. European Respiratory Journal. 42(Suppl 57). P2351–P2351. 2 indexed citations
14.
Kida, Yoshiko, Shinichiro Ohshimo, Kohei Ota, et al.. (2012). KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome. Orphanet Journal of Rare Diseases. 7(1). 99–99. 3 indexed citations
15.
Otani, Takuya, Shinichiro Ohshimo, Tomoki Shokawa, et al.. (2011). A survey on laypersons' willingness in performing cardiopulmonary resuscitation. Critical Care. 15(S1). 2 indexed citations
16.
Kondo, Tomohiro, Noboru Hattori, Nobuhisa Ishikawa, et al.. (2011). KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome. Respiratory Research. 12(1). 32–32. 39 indexed citations
17.
Liu, Liangji, Koichi Tanigawa, Tomoko Tamura, et al.. (2010). Tracheal Intubation of a Difficult Airway Using Airway Scope, Airtraq, and Macintosh Laryngoscope. Anesthesia & Analgesia. 110(4). 1049–1055. 29 indexed citations
18.
Hirohashi, Nobuyuki, et al.. (1999). LPS pretreatment of mouse peritoneal macrophages differentially modulates TNFα and iNOS expression. Journal of Endotoxin Research. 5(5-6). 251–260. 3 indexed citations
19.
Amura, Claudia R., Lung‐Chi Chen, Nobuyuki Hirohashi, Mei G. Lei, & David C. Morrison. (1997). Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. The Journal of Immunology. 159(10). 5079–5083. 25 indexed citations
20.
Nakao, Masanobu, Akinori Hara, Nobuyuki Hirohashi, et al.. (1993). A Monoclonal Antibody (H227) Recognizing a New Epitope of 4F2 Molecular Complex Associated with T Cell Activation. Cellular Immunology. 152(1). 226–233. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence C. Mohr Breakdown of academic impact, for papers by H-Erich Wichmann Breakdown of academic impact, for papers by Catherine Mitchell Breakdown of academic impact, for papers by Dillwyn Williams Breakdown of academic impact, for papers by Uwe Kaletsch Breakdown of academic impact, for papers by Zhiguang Zhao Breakdown of academic impact, for papers by Wann‐Cherng Perng Breakdown of academic impact, for papers by Yoonki Hong Breakdown of academic impact, for papers by Xiaosong Ben
Rankless by CCL
2026